BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 23506684)

  • 1. Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers.
    Zvelebil M; Oliemuller E; Gao Q; Wansbury O; Mackay A; Kendrick H; Smalley MJ; Reis-Filho JS; Howard BA
    Breast Cancer Res; 2013 Mar; 15(2):R25. PubMed ID: 23506684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
    Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
    Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium.
    Meier-Abt F; Milani E; Roloff T; Brinkhaus H; Duss S; Meyer DS; Klebba I; Balwierz PJ; van Nimwegen E; Bentires-Alj M
    Breast Cancer Res; 2013 Apr; 15(2):R36. PubMed ID: 23621987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.
    Burga LN; Hu H; Juvekar A; Tung NM; Troyan SL; Hofstatter EW; Wulf GM
    Breast Cancer Res; 2011 Mar; 13(2):R30. PubMed ID: 21396117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sox11 regulates mammary tumour-initiating and metastatic capacity in Brca1-deficient mouse mammary tumour cells.
    Tsang SM; Kim H; Oliemuller E; Newman R; Boateng NA; Guppy N; Howard BA
    Dis Model Mech; 2021 May; 14(5):. PubMed ID: 33969421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trp63 is regulated by STAT5 in mammary tissue and subject to differentiation in cancer.
    Assefnia S; Kang K; Groeneveld S; Yamaji D; Dabydeen S; Alamri A; Liu X; Hennighausen L; Furth PA
    Endocr Relat Cancer; 2014 Jun; 21(3):443-57. PubMed ID: 24692510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers.
    Smalley MJ; Iravani M; Leao M; Grigoriadis A; Kendrick H; Dexter T; Fenwick K; Regan JL; Britt K; McDonald S; Lord CJ; Mackay A; Ashworth A
    Breast Cancer Res; 2007; 9(6):R85. PubMed ID: 18067675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
    Wang C; Bai F; Zhang LH; Scott A; Li E; Pei XH
    Breast Cancer Res; 2018 Jul; 20(1):74. PubMed ID: 29996906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance.
    Dabydeen SA; Kang K; Díaz-Cruz ES; Alamri A; Axelrod ML; Bouker KB; Al-Kharboosh R; Clarke R; Hennighausen L; Furth PA
    Carcinogenesis; 2015 Jan; 36(1):122-32. PubMed ID: 25421723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APRIL promotes breast tumor growth and metastasis and is associated with aggressive basal breast cancer.
    García-Castro A; Zonca M; Florindo-Pinheiro D; Carvalho-Pinto CE; Cordero A; Gutiérrez del Fernando B; García-Grande A; Mañes S; Hahne M; González-Suárez E; Planelles L
    Carcinogenesis; 2015 May; 36(5):574-84. PubMed ID: 25750171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.
    Stein T; Price KN; Morris JS; Heath VJ; Ferrier RK; Bell AK; Pringle MA; Villadsen R; Petersen OW; Sauter G; Bryson G; Mallon EA; Gusterson BA
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6872-9. PubMed ID: 16203777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A8 identifies a subpopulation of transiently quiescent c-kit positive luminal progenitor cells of the ductal mammary epithelium.
    Iglesias JM; Cairney CJ; Ferrier RK; McDonald L; Soady K; Kendrick H; Pringle MA; Morgan RO; Martin F; Smalley MJ; Blyth K; Stein T
    PLoS One; 2015; 10(3):e0119718. PubMed ID: 25803307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.
    Mehner C; Hockla A; Miller E; Ran S; Radisky DC; Radisky ES
    Oncotarget; 2014 May; 5(9):2736-49. PubMed ID: 24811362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.
    Dunlap SM; Chiao LJ; Nogueira L; Usary J; Perou CM; Varticovski L; Hursting SD
    Cancer Prev Res (Phila); 2012 Jul; 5(7):930-42. PubMed ID: 22588949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct FAK activities determine progenitor and mammary stem cell characteristics.
    Luo M; Zhao X; Chen S; Liu S; Wicha MS; Guan JL
    Cancer Res; 2013 Sep; 73(17):5591-602. PubMed ID: 23832665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
    Pal B; Chen Y; Bert A; Hu Y; Sheridan JM; Beck T; Shi W; Satterley K; Jamieson P; Goodall GJ; Lindeman GJ; Smyth GK; Visvader JE
    Breast Cancer Res; 2015 Jun; 17(1):85. PubMed ID: 26080807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.
    Ma Y; Katiyar P; Jones LP; Fan S; Zhang Y; Furth PA; Rosen EM
    Mol Endocrinol; 2006 Jan; 20(1):14-34. PubMed ID: 16109739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-6 integrin deletion delays the formation of Brca1/p53-deficient basal-like breast tumors by restricting luminal progenitor cell expansion.
    Faraldo MM; Romagnoli M; Wallon L; Dubus P; Deugnier MA; Fre S
    Breast Cancer Res; 2024 Jun; 26(1):91. PubMed ID: 38835038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Isoforms of the RNA Binding Protein, Coding Region Determinant-binding Protein (CRD-BP/IGF2BP1), Are Expressed in Breast Epithelium and Support Clonogenic Growth of Breast Tumor Cells.
    Fakhraldeen SA; Clark RJ; Roopra A; Chin EN; Huang W; Castorino J; Wisinski KB; Kim T; Spiegelman VS; Alexander CM
    J Biol Chem; 2015 May; 290(21):13386-400. PubMed ID: 25861986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.
    Chen F; Li A; Gao S; Hollern D; Williams M; Liu F; VanSickle EA; Andrechek E; Zhang C; Yang C; Luo R; Xiao H
    Cell Death Dis; 2014 May; 5(5):e1242. PubMed ID: 24853420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.